Lim, S., Reynolds, J., Pemberton, L., Wright, T., Lee, S., Mollee, P., Shetty, A. C., Kim, Y. J., Helen, W., Nina, B., Le, K., McQuilten, Z., Quach, H., Spencer, A. (2025). Updated results from the frailty-stratified, randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant ineligible myeloma (TI NDMM) – the FRAIL-m study (AMaRC 19-01; ALLG MM22). Blood. https://doi.org/10.1182/blood-2025-5842